Looks like Radient is finally going to make someone some money...the lawyers. If this goes down as per the PR looks like Rosen is going to pocket more money than the total sales revenue for DR-70/Onko-Sur during its entire patent lifetime. Think about that one for a minute. JMHO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.